Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| COZADD BRUCE C | Dec 2, 2024 | Sell | 2,000 | $121.17 | $240,000 |
| Carr Patricia | Dec 2, 2024 | Sell | 53 | $122.49 | $6,500 |
| Patil Neena M | Nov 8, 2024 | Sell | 3,700 | $123.41 | $460,000 |
| COZADD BRUCE C | Nov 1, 2024 | Sell | 1,000 | $110.84 | $110,000 |
| Henderson Mary Elizabeth | Sep 6, 2024 | Sell | 1,410 | $108.3 | $150,000 |
| Carr Patricia | Jun 7, 2024 | Sell | 163 | $108.825 | $18,000 |
| Patil Neena M | May 3, 2024 | Sell | 5,000 | $109.65 | $550,000 |
| Carr Patricia | Mar 7, 2024 | Sell | 1,768 | $116.98 | $210,000 |
| Carr Patricia | Mar 6, 2024 | Sell | 1,236 | $120.85 | $150,000 |
| Carr Patricia | Mar 6, 2024 | Sell | 700 | $117.51 | $82,000 |
| Johnson Philip L | Mar 1, 2024 | Buy | 12,000 | $119.65 | $1.4M |
| Smith Mark Douglas | Dec 4, 2023 | Sell | 417 | $119.27 | $50,000 |
| Cook Jennifer E. | Dec 4, 2023 | Sell | 417 | $119.27 | $50,000 |
| Carr Patricia | Dec 4, 2023 | Sell | 50 | $121.3947 | $6,100 |
| Patil Neena M | Sep 1, 2023 | Sell | 1,500 | $144.25 | $220,000 |
| Carr Patricia | Aug 29, 2023 | Sell | 142 | $143.4686 | $20,000 |
| Patil Neena M | Aug 15, 2023 | Sell | 750 | $139.5933 | $100,000 |
| ORiordan Anne | Aug 14, 2023 | Sell | 1,241 | $138.158 | $170,000 |
| O'Keefe Kenneth W | Aug 14, 2023 | Sell | 1,241 | $138.1585 | $170,000 |
| Winningham Rick E | Aug 14, 2023 | Sell | 1,241 | $138.1584 | $170,000 |
| Sohn Catherine A. | Aug 14, 2023 | Sell | 1,241 | $138.1585 | $170,000 |
| Smith Mark Douglas | Aug 14, 2023 | Sell | 1,241 | $138.1579 | $170,000 |
| RIEDEL NORBERT G | Aug 14, 2023 | Sell | 1,241 | $138.1581 | $170,000 |
| McSharry Heather Ann | Aug 14, 2023 | Sell | 1,344 | $138.1586 | $190,000 |
| Gray Peter | Aug 14, 2023 | Sell | 1,241 | $138.1584 | $170,000 |
| ENRIGHT PATRICK G | Aug 14, 2023 | Sell | 1,241 | $138.1585 | $170,000 |
| Cook Jennifer E. | Aug 14, 2023 | Sell | 1,241 | $138.1581 | $170,000 |
| Carr Patricia | Aug 14, 2023 | Sell | 158 | $138.1575 | $22,000 |
| Carr Patricia | Jun 7, 2023 | Sell | 126 | $127.916 | $16,000 |
| Patil Neena M | Jun 1, 2023 | Sell | 1,526 | $127.9751 | $200,000 |
| Patil Neena M | Jun 1, 2023 | Sell | 74 | $128.015 | $9,500 |
| GALA RENEE D | May 18, 2023 | Sell | 6,000 | $131.7457 | $790,000 |
| Carr Patricia | Mar 15, 2023 | Sell | 1,023 | $133.22 | $140,000 |
| Sablich Kim | Mar 8, 2023 | Sell | 1,752 | $139.42 | $240,000 |
| Sablich Kim | Mar 8, 2023 | Sell | 1,261 | $140.19 | $180,000 |
| O'Keefe Kenneth W | Mar 7, 2023 | Sell | 2,690 | $138.3894 | $370,000 |
| Larkin Finbar | Mar 7, 2023 | Sell | 2,075 | $140.7619 | $290,000 |
| Larkin Finbar | Mar 6, 2023 | Sell | 1,706 | $143.919 | $250,000 |
| Carr Patricia | Mar 5, 2023 | Sell | 1,148 | $140.7612 | $160,000 |
| Pearce Samantha | Feb 2, 2023 | Sell | 531 | $157.26 | $84,000 |
| COZADD BRUCE C | Feb 1, 2023 | Sell | 1,000 | $155.79 | $160,000 |
| COZADD BRUCE C | Jan 3, 2023 | Sell | 2,000 | $160 | $320,000 |
| COZADD BRUCE C | Jan 3, 2023 | Sell | 1,000 | $159.59 | $160,000 |
| Pearce Samantha | Jan 3, 2023 | Sell | 531 | $159.59 | $85,000 |
What's the latest insider transaction for Jazz Pharmaceuticals?
The most recent insider transaction for Jazz Pharmaceuticals was conducted by COZADD BRUCE C, who sold 2,000 shares on December 2, 2024 at a price of $121.17 per share.
Which insider bought the most JAZZ stock over the last two years?
Johnson Philip L has bought the most JAZZ stock in the last 2 years, with a total value of $1.4M.
Which insider has sold the most JAZZ stock over the last two years?
Patil Neena M has sold the most JAZZ stock in the last 2 years, with a total value of $1.5M.
What is the total value of insider transactions for Jazz Pharmaceuticals (JAZZ) in the last 2 years?
The total value of insider transactions for Jazz Pharmaceuticals in the last 2 years is negative, amounting to -$6.2M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Jazz Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Jazz Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
